Warning: Trying to access array offset on value of type bool in /home/customer/www/medtechwomen.org/public_html/wp-content/themes/medtechwomen/partials/content-single-event.php on line 11

Past Event

This year’s interactive discussion will focus on the power that patients possess to bring change to our industry, and how we as a community of business leaders, physicians, policymakers, and investors can channel this spirit into solutions.

Conference Agenda

Opening Keynote Speaker
8:30 – 9:30 AM
Victoria Nahum, Founder, Safe Care Campaign

Panel #1: Giving More Patients Access to Innovation: Strategies and Tactics for Domestic and International Market Development
9:30 – 10:45 AM

This panel discusses several key components of market development via 3 case studies of market development efforts in US, Europe, and Asia. Market development can be defined many different ways, and each case study will draw out different aspects as the panelists address their distinct challenges and the resulting insights. The case study structure enables coverage of a broad range of topics while still providing concrete, actionable, real-world insights and solutions. The panelists will discuss topics such as generating awareness of new clinical options among patients and their physicians, changing clinical guidelines and protocols to reflect new advancements, driving reimbursement for valuable therapies, leveraging enabling technology to alter patient care paradigms, and working around infrastructure gaps to give patients access to care.

10:45 – 11:00 AM

Panel #2: The Internet’s Impact on Patient Health Management, Care Delivery, and Choice
11:00 – 12:00 PM
This panel discussion will focus on the evolving impact of the Internet and social media on patient empowerment, healthcare delivery, and the med-tech innovation landscape. The panelists will speak to the unifying theme of the rising influence of the patient in their own healthcare decisions, and how the Internet has directly impacted patient knowledge, informed choice, and participation in their own health management. The panel will provide broader perspectives on how this is being manifested in companies that provide these types of services and how the investment community is thinking about opportunities in this space.

Networking Lunch Session
12:00 PM

Panel #3: Stakeholder Roles in Patient Advocacy
1:15 – 2:15 PM
“Patient advocacy” has become an increasingly used phrase to reflect many types of relationships between patients and both providers and payers in the optimal delivery of healthcare. Patient advocates can be individuals or organizations, may be for-profit or nonprofit, can focus on single or multiple diseases, and/or may limit their scope to very specific components or settings of care. However, a common denominator is that these advocates are increasingly driven to help patients help themselves, a concept that this panel will explore from various stakeholder viewpoints.

  • Anne Abreu, Director Reimbursement, Sonitus Medical
  • Amy DuRoss, Vice President, Policy and Business Affairs, Navigenics
  • Catherine Carver, Vice President, Planning and Advocacy, Joslin Diabetes Center
  • Donna Cryer, Chairman of the Board, American Liver Foundation; CEO, CryerHealth LLC

Panel #4: CEO Roundtable
2:15 – 3:00 PM
The med-tech landscape is changing both in terms of who is leading the companies and what competencies CEOs and their teams must have to be successful. This panel will hear perspectives from experienced CEOs on the latest trends in healthcare and how this has impacted their business strategy.

3:00 – 3:15 PM

Meet the CEO Panel (Break-out Session)
3:15 – 4:00 PM

Panel #5: Walking the Healthcare Tightrope: How Innovation Will Be Shaped by the Tension Between the Patient’s Voice and the System’s Willingness to Pay
4:00 – 5:00 PM
Patients today are empowered as never before. They have access via the Internet to virtually all the same data as physicians. And in many diseases there are well-organized patient groups that are playing roles, from funding the development of novel therapies, to helping enroll clinical trials, to informing fellow patients what therapies work best. The development of biomarkers is also making truly personalized treatment possible, particularly in cancer. But if all of this empowers patients, the trend in how healthcare is paid for is moving in precisely the opposite direction. As more and more care is paid for by organizations—whether private insurers or governments—it is these organizations that are deciding which drugs, procedures, and devices will be reimbursed and for whom. Indeed, this trend threatens to limit the decision-making role of both patients and doctors and puts decisions instead in the hands of large bureaucracies. This panel will address how these countervailing forces will affect healthcare innovation going forward.

Informal Networking Session
5:30 PM

Keynote Speaker – Evening Event
6:30 PM
Molly J. Coye, Chief Innovation Officer, UCLA Health System

View All Past Events

Share This